Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) closed at $596.85 in the last session, down -1.29% from day before closing price of $604.62. In other words, the price has decreased by -$1.29 from its previous closing price. On the day, 0.87 million shares were traded.
Ratios:
We take a closer look at REGN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.77. For the most recent quarter (mrq), Quick Ratio is recorded 4.03 and its Current Ratio is at 4.93. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Leerink Partners Upgraded its Market Perform to Outperform on February 05, 2025, whereas the target price for the stock was revised from $762 to $834.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 01 ’24 when McCourt Marion sold 1,000 shares for $844.61 per share. The transaction valued at 844,610 led to the insider holds 12,931 shares of the business.
MARION E MCCOURT bought 1,000 shares of REGN for $844,610 on Nov 01 ’24. On Oct 01 ’24, another insider, RYAN ARTHUR F, who serves as the Director of the company, sold 100 shares for $1048.78 each. As a result, the insider received 104,878 and left with 17,582 shares of the company.
Valuation Measures:
As of this moment, Regeneron’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.19, and their Forward P/E ratio for the next fiscal year is 15.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 8.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.57 while its Price-to-Book (P/B) ratio in mrq is 2.20.
Stock Price History:
Over the past 52 weeks, REGN has reached a high of $1211.20, while it has fallen to a 52-week low of $520.50. The 50-Day Moving Average of the stock is -0.61%, while the 200-Day Moving Average is calculated to be -25.85%.
Shares Statistics:
A total of 106.40M shares are outstanding, with a floating share count of 104.06M. Insiders hold about 3.61% of the company’s shares, while institutions hold 87.04% stake in the company.
